Acton Pharma gets USFDA nod for an inhaled steroid to treat asthma

By Admin
Acton Pharmaceuticals, Inc Friday said it has secured approval from the U.S. Food and Drug Administration of its supplemental New Drug Application for...

Acton Pharmaceuticals, Inc Friday said it has secured approval from the U.S. Food and Drug Administration of its supplemental New Drug Application for an inhaled steroid to treat asthma, the news reports said.

The FDA approved the application for AEROSPAN, an oral corticosteroid used in treating asthma in adults and kids six and under.

Post getting the approval, the respiratory therapeutics company now plans to launch AEROSPAN into $8.3 billion inhaled steroid market in early 2013, the company said.

Acton Pharma bought AEROSPAN new drug application under the licensing agreement with Forest Laboratories, Inc in 2009.

Acton President Daniel Kreisler said, “Acton anticipates commercial launch of AEROSPAN in the first quarter of 2013 as we build out our sales and marketing infrastructure and evaluate strategic partnerships.” Mr. Kreisler also said, “Our ongoing commercial preparations include building product inventory as well as finalizing the introduction of Aerospan to manage care plans and initiation of pre-launch marketing activities.”

As per the Center for Disease Control, there are more than 24 million Americans with asthma and the disease is the cause for nearly 2 million emergency visits each and $11.5 billion in healthcare costs.

Acton Pharmaceuticals, Inc is a respiratory specialty pharmaceutical company. It focuses on acquisition, development, and commercialization of products to treat allergic, pulmonary, and other respiratory related diseases.

Share
Share

Featured Articles

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability